SRF shares climb 4% on Axis Capital upgrade despite target cut
Axis Capital said the company’s chemical business offers healthy medium-term growth potential and expects a 23% CAGR in this segment over FY25 to FY28.
Source link
Get latast news super fast
Axis Capital said the company’s chemical business offers healthy medium-term growth potential and expects a 23% CAGR in this segment over FY25 to FY28.
Source link